- Home
- CON vs CPRX Comparison
CON vs CPRX Comparison
Compare CON & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CON
- CPRX
- Stock Information
- Founded
- CON 1979
- CPRX 2002
- Country
- CON United States
- CPRX United States
- Employees
- CON N/A
- CPRX N/A
- Industry
- CON
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- CON
- CPRX Health Care
- Exchange
- CON NYSE
- CPRX Nasdaq
- Market Cap
- CON 2.7B
- CPRX 2.9B
- IPO Year
- CON 2024
- CPRX 2006
- Fundamental
- Price
- CON $20.76
- CPRX $21.61
- Analyst Decision
- CON Strong Buy
- CPRX Strong Buy
- Analyst Count
- CON 7
- CPRX 6
- Target Price
- CON $29.00
- CPRX $32.83
- AVG Volume (30 Days)
- CON 787.2K
- CPRX 1.4M
- Earning Date
- CON 07-31-2025
- CPRX 08-06-2025
- Dividend Yield
- CON 1.21%
- CPRX N/A
- EPS Growth
- CON N/A
- CPRX 178.13
- EPS
- CON 1.30
- CPRX 1.57
- Revenue
- CON $1,933,346,000.00
- CPRX $534,645,999.00
- Revenue This Year
- CON $13.09
- CPRX $16.37
- Revenue Next Year
- CON $7.35
- CPRX $8.80
- P/E Ratio
- CON $15.91
- CPRX $13.83
- Revenue Growth
- CON 4.54
- CPRX 29.97
- 52 Week Low
- CON $18.89
- CPRX $14.97
- 52 Week High
- CON $24.81
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- CON N/A
- CPRX 33.25
- Support Level
- CON N/A
- CPRX $21.69
- Resistance Level
- CON N/A
- CPRX $23.91
- Average True Range (ATR)
- CON 0.00
- CPRX 0.77
- MACD
- CON 0.00
- CPRX -0.37
- Stochastic Oscillator
- CON 0.00
- CPRX 9.46
About CON CONCENTRA GROUP HOLDINGS PARENT INC
Concentra Group Holdings Parent Inc is a provider of occupational health services in the United States. The business is organized into three operating segments: occupational health centers, onsite health clinics, and other businesses.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).